Pablo G. Legorreta - 30 Dec 2022 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role
CEO, Chairman of the Board, Director, 10%+ Owner
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for Pablo G. Legorreta
Issuer symbol
RPRX
Transactions as of
30 Dec 2022
Net transactions value
$0
Form type
4
Filing time
16 Nov 2023, 17:50:58 UTC
Previous filing
16 Aug 2022
Next filing
10 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPRX Class A ordinary shares Gift $0 +292,190 $0.000000 292,190 30 Dec 2022 By Tata MC 35 Ltd.
transaction RPRX Class A ordinary shares Other $0 -383,000 -86% $0.000000 63,795 16 Nov 2023 Direct F1, F2
holding RPRX Class A ordinary shares 600,000 30 Dec 2022 By Legorreta 2023 SR Trust
holding RPRX Class A ordinary shares 460,139 30 Dec 2022 By Legorreta Investments LLC
holding RPRX Class A ordinary shares 901,590 30 Dec 2022 By GST-Exempt Legorreta 2012 Family Trust
holding RPRX Class A ordinary shares 41,306 30 Dec 2022 By GST-Exempt Legorreta 2020 Family Trust
holding RPRX Class A ordinary shares 10,000 30 Dec 2022 By Child
holding RPRX Class A ordinary shares 10,000 30 Dec 2022 By Child
holding RPRX Class A ordinary shares 123,310 30 Dec 2022 By IRRA
holding RPRX Class A ordinary shares 118,500 30 Dec 2022 By SEP/IRA
holding RPRX Class A ordinary shares 1,040,410 30 Dec 2022 By Legorreta Children 2002 Trust
holding RPRX Class A ordinary shares 6,930 30 Dec 2022 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the transfer by the Reporting Person of Class A ordinary shares for no consideration to RP Management Equity Incentive Plan Trust.
F2 Reflects the exempt transfer pursuant to Rule 16a-13 of Class A ordinary shares from the GST-Exempt Legorreta 2012 Family Trust.